Founder and Principal Infection Prevention Partners, California
I do not have any relevant financial / non-financial relationships with any proprietary interests.
• Review the rise in rates of Multi-Drug Resistant Organisms (MDROs) in the wake of COVID-19
• Explain the implications of Antimicrobial Resistance (AMR) on human health and infection prevention practice
• Discuss the ways in which screening can be employed in the identification, prevention, and control of MDROs
• Describe how the early use of molecular diagnostics provides the opportunity to define optimal therapeutic strategies and enhance infection control resources
